Atlas Trials

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

Clinical trial NCT06246630 · UNKNOWN

Trial details

NCT number
NCT06246630
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Advanced Pancreatic Neuroendocrine Tumor
Start date
2024-04-03
Primary completion
2025-12-25
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.